NUTRALIFE BIOSCIENCES, INC. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4ddf0f15-b001-4456-9bd7-121e0b18e948/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $626.6k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-009623 |
| FY 2020 | $1.3M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-015197 |
| FY 2019 | $2.1M | 2019-01-01 – 2019-12-31 | evidence 0001493152-21-006466 |
| FY 2018 | $3.7M | 2018-01-01 – 2018-12-31 | evidence 0001493152-21-006466 |
| FY 2017 | $1.8M | 2017-01-01 – 2017-12-31 | evidence 0001477932-19-001448 |
| FY 2016 | $225.3k | 2016-01-01 – 2016-12-31 | evidence 0001511164-18-000246 |
| FY 2014 | $62.3k | 2014-01-01 – 2014-12-31 | evidence 0001511164-15-000232 |
| FY 2013 | $479.3k | 2013-01-01 – 2013-12-31 | evidence 0001511164-15-000232 |
| FY 2012 | $126.6k | 2012-01-01 – 2012-12-31 | evidence 0001511164-14-000236 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NUTRALIFE BIOSCIENCES, INC. — all facts · Net Income · Operating Income